Kiwoom Securities Issues KRW 40 Billion in Bio Leverage and Power Inverse 2X ETNs

Kiwoom Securities issued two ETNs totaling KRW 40 billion on May 11, 2026 (KRW 20 billion each, KRW 20,000 per certificate).
Products: 'Kiwoom Leverage Bio TOP10 ETN #15' (tracking KEDI Bio TOP10 Leverage (x2) index, maturity Nov 1, 2027) and 'Kiwoom Inverse 2X Power TOP5 ETN #27' (tracking iSelect Power TOP5 TR Inverse-2X index, maturity Feb 9, 2029).
Both are non-principal-protected and not covered by depositor protection.
Total annual expense ratio: 0.95% (management fee 0.22-0.39%, other costs included).
Issuer credit rating: Kiwoom Securities AA (NICE, Korea Credit Rating, as of March 2026).
Risks: Early liquidation possible if IIV drops 80% from previous day or falls below KRW 1,000.
Early redemption fee: 2.0%, minimum 50,000 certificates.
Liquidity provider: Kiwoom Securities, required to maintain maximum bid-ask spread of 1.0%.